evidence table

Olive Leaf Blood Glucose Meta-Analysis Evidence Table

Structured evidence table for Olive Leaf Blood Glucose Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Olive Leaf Blood Glucose Meta-AnalysisResearch shows that olive polyphenols (oleuropein, hydroxytyrosol, luteolin, and oleocanthal), as well as pomegranate polyphenols (punicalagin, urolithin A, ellagic acid), inhibit cyclooxygenase and lipoxygenase enzymes, which are associated with inflammatory processes.1Vučina R (2026)Enzyme Inhibition by Bioactive Compounds from Olive (<i>Olea europaea</i> L.) and Pomegranate (<i>Punica granatum</i> L.): Systematic Review of In Vitro Studies.
Olive Leaf Blood Glucose Meta-AnalysisThe current evidence supports the view that olive and pomegranate polyphenols act as biologically versatile compounds with considerable pharmaceutical and nutraceutical potential.1Vučina R (2026)Enzyme Inhibition by Bioactive Compounds from Olive (<i>Olea europaea</i> L.) and Pomegranate (<i>Punica granatum</i> L.): Systematic Review of In Vitro Studies.
Olive Leaf Blood Glucose Meta-AnalysisFuture investigations integrating enzymology, metabolomics, molecular docking, and clinical validation will be essential for translating these promising in vitro findings into evidence-based therapeutic applications.1Vučina R (2026)Enzyme Inhibition by Bioactive Compounds from Olive (<i>Olea europaea</i> L.) and Pomegranate (<i>Punica granatum</i> L.): Systematic Review of In Vitro Studies.
Olive Leaf Blood Glucose Meta-AnalysisCompounds from olive ( Olea europaea L.) and pomegranate (Punica granatum L.) have many beneficial effects on human health.1Vučina R (2026)Enzyme Inhibition by Bioactive Compounds from Olive (<i>Olea europaea</i> L.) and Pomegranate (<i>Punica granatum</i> L.): Systematic Review of In Vitro Studies.
Olive Leaf Blood Glucose Meta-AnalysisThe declining CVD mortality rate that was observed remained stable in the last years or even increased in some populations [,].2Lauwers Stef (2026)Evaluation of the effect of olive extracts on blood pressure and cardiovascular health markers in adults: Findings from a double-blind, placebo-controlled, randomised trial
Olive Leaf Blood Glucose Meta-Analysis5 6 7 8 Poor management of factors, such as diet, physical activity, blood lipids, and blood pressure, will increase the risk of developing CVD as a 20 mmHg increase in systolic blood pressure (SBP) is associated with a doubled risk of death from CVD [,].2Lauwers Stef (2026)Evaluation of the effect of olive extracts on blood pressure and cardiovascular health markers in adults: Findings from a double-blind, placebo-controlled, randomised trial
Olive Leaf Blood Glucose Meta-AnalysisCVD risk factors often occur clustered, as hypertension is linked to dyslipidaemia, impaired glucose tolerance and type 2 diabetes [,].2Lauwers Stef (2026)Evaluation of the effect of olive extracts on blood pressure and cardiovascular health markers in adults: Findings from a double-blind, placebo-controlled, randomised trial
Olive Leaf Blood Glucose Meta-Analysis1 2 3 4 Over the past few decades, remarkable progress has been made in developing strategies to lower the incidence of cardiovascular diseases (CVD).2Lauwers Stef (2026)Evaluation of the effect of olive extracts on blood pressure and cardiovascular health markers in adults: Findings from a double-blind, placebo-controlled, randomised trial
topicOlive Leaf Blood Glucose Meta-Analysis
claimResearch shows that olive polyphenols (oleuropein, hydroxytyrosol, luteolin, and oleocanthal), as well as pomegranate polyphenols (punicalagin, urolithin A, ellagic acid), inhibit cyclooxygenase and lipoxygenase enzymes, which are associated with inflammatory processes.
evidence level1
citationVučina R (2026)
sourceEnzyme Inhibition by Bioactive Compounds from Olive (<i>Olea europaea</i> L.) and Pomegranate (<i>Punica granatum</i> L.): Systematic Review of In Vitro Studies.
topicOlive Leaf Blood Glucose Meta-Analysis
claimThe current evidence supports the view that olive and pomegranate polyphenols act as biologically versatile compounds with considerable pharmaceutical and nutraceutical potential.
evidence level1
citationVučina R (2026)
sourceEnzyme Inhibition by Bioactive Compounds from Olive (<i>Olea europaea</i> L.) and Pomegranate (<i>Punica granatum</i> L.): Systematic Review of In Vitro Studies.
topicOlive Leaf Blood Glucose Meta-Analysis
claimFuture investigations integrating enzymology, metabolomics, molecular docking, and clinical validation will be essential for translating these promising in vitro findings into evidence-based therapeutic applications.
evidence level1
citationVučina R (2026)
sourceEnzyme Inhibition by Bioactive Compounds from Olive (<i>Olea europaea</i> L.) and Pomegranate (<i>Punica granatum</i> L.): Systematic Review of In Vitro Studies.
topicOlive Leaf Blood Glucose Meta-Analysis
claimCompounds from olive ( Olea europaea L.) and pomegranate (Punica granatum L.) have many beneficial effects on human health.
evidence level1
citationVučina R (2026)
sourceEnzyme Inhibition by Bioactive Compounds from Olive (<i>Olea europaea</i> L.) and Pomegranate (<i>Punica granatum</i> L.): Systematic Review of In Vitro Studies.
topicOlive Leaf Blood Glucose Meta-Analysis
claimThe declining CVD mortality rate that was observed remained stable in the last years or even increased in some populations [,].
evidence level2
citationLauwers Stef (2026)
sourceEvaluation of the effect of olive extracts on blood pressure and cardiovascular health markers in adults: Findings from a double-blind, placebo-controlled, randomised trial
topicOlive Leaf Blood Glucose Meta-Analysis
claim5 6 7 8 Poor management of factors, such as diet, physical activity, blood lipids, and blood pressure, will increase the risk of developing CVD as a 20 mmHg increase in systolic blood pressure (SBP) is associated with a doubled risk of death from CVD [,].
evidence level2
citationLauwers Stef (2026)
sourceEvaluation of the effect of olive extracts on blood pressure and cardiovascular health markers in adults: Findings from a double-blind, placebo-controlled, randomised trial
topicOlive Leaf Blood Glucose Meta-Analysis
claimCVD risk factors often occur clustered, as hypertension is linked to dyslipidaemia, impaired glucose tolerance and type 2 diabetes [,].
evidence level2
citationLauwers Stef (2026)
sourceEvaluation of the effect of olive extracts on blood pressure and cardiovascular health markers in adults: Findings from a double-blind, placebo-controlled, randomised trial
topicOlive Leaf Blood Glucose Meta-Analysis
claim1 2 3 4 Over the past few decades, remarkable progress has been made in developing strategies to lower the incidence of cardiovascular diseases (CVD).
evidence level2
citationLauwers Stef (2026)
sourceEvaluation of the effect of olive extracts on blood pressure and cardiovascular health markers in adults: Findings from a double-blind, placebo-controlled, randomised trial

Learn next

Related evidence and supplement guides

SupplementBerberinePlant alkaloid with clinical evidence rivalling metformin for blood glucose control and lipid ma...GuideOlive Leaf Blood Lipids Meta-analysis: What the Evidence SaysOlive Leaf Blood Lipids Meta-analysis has 2 source documents in the current Migaku evidence data...GuideOlive Leaf Blood Glucose Randomized Trial: What the Evidence SaysOlive Leaf Blood Glucose Randomized Trial has 2 source documents in the current Migaku evidence...GuideGinseng Blood Glucose Meta-analysis: What the Evidence SaysGinseng Blood Glucose Meta-analysis has 2 source documents in the current Migaku evidence databa...GuideGarlic Blood Glucose Meta-analysis: What the Evidence SaysGarlic Blood Glucose Meta-analysis has 1 source documents in the current Migaku evidence databas...AnswerDoes Olive Leaf Blood Lipids Meta-Analysis work?Olive Leaf Blood Lipids Meta-Analysis has evidence relevant to strength of evidence and what the...AnswerIs Olive Leaf Blood Lipids Meta-Analysis safe?Olive Leaf Blood Lipids Meta-Analysis has evidence relevant to safety, limits, and clinician-dis...AnswerWhat does the evidence say about Olive Leaf Blood Lipids Meta-Analysis?Olive Leaf Blood Lipids Meta-Analysis has evidence relevant to benefits, uncertainty, and practi...

Source documents

  1. Enzyme Inhibition by Bioactive Compounds from Olive (<i>Olea europaea</i> L.) and Pomegranate (<i>Punica granatum</i> L.): Systematic Review of In Vitro Studies.
  2. Evaluation of the effect of olive extracts on blood pressure and cardiovascular health markers in adults: Findings from a double-blind, placebo-controlled, randomised trial